Elicit Enters Pharma Target Screening
elicitorg · x · 2026-07-18
Orion Pharma is integrating Elicit into early-stage drug discovery decisions, specifically for target prioritization. The Elicit team notes that tasks previously taking scientists weeks to manually search, read, and synthesize literature can now be completed faster and cover a broader research scope.
The post mentions that Orion started using Elicit for Reports and Systematic Literature Reviews, later expanding into more workflows following the release of Research Agent. Client feedback indicates that what used to be a "paper by paper" process now takes less time, enabling the same team to evaluate more targets and make more confident go/no-go decisions.
Related event: Orion Pharma Brings Elicit Into Early Drug Research(3 posts)→
More from Companies & People
- Interpretability researcher mathildepapillo joins Goodfire post-PhD, calls interp the key problem — mathildepapillo · 2026-10-27
- UCSB CS Prof. Xifeng Wang lands 3 grants worth $180K+ for practical agentic AI research — xwang_lk · 2026-10-27
- EMNLP keynote: industry does read academic NLP papers, it just rarely credits them — srchvrs · 2026-10-27
- Anthropic's $80B "loss" is mostly convertible-note accounting, not cash burn — beffjezos · 2026-10-27
- Anthropic's IPO filing reveals unusual succession plan: confidential ranked lists of up to 10 successors per founder — annatonger · 2026-10-27
- University of Freiburg's Generative Intelligence Lab recruiting funded PhDs via ELLIS, apply by Oct 31 — yuyinzhou_cs · 2026-10-27